Physician profile
Robert J Wilmoth
NPI 1073505962
$300.39
in general payments reported to CMS, 2019-2025
10 companies · $42.23 in 2025
The $42.23 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.06 · 2021: $48.62 · 2022: $123 · 2023: $74.34 · 2025: $42.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $116.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $79.69 | 2022 | |
| Ethicon US, LLC | $72.89 | 2022-2025 | Echelon Flex, Echelon; Endopath |
| Smith+Nephew, INC. | $42.62 | 2021-2023 | Renasys Go V2 Home |
| Vertex Pharmaceuticals Incorporated | $24.82 | 2025 | |
| Medtronic, INC. | $15.61 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.16 | 2023 | Seglentis |
| Boston Scientific Corporation | $13.59 | 2022 | |
| Ambu INC. | $13.41 | 2023 | |
| Covidien LP | $12.06 | 2019 | |
| Leica Microsystems INC. | $11.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wilmoth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.